Here, we reported the development of a novel blood-based model using four CRC-specific DNA methylation markers, c9orf50, kcnj12, znf132 and twist1, and demonstrated its potential for the detection of CRC in routine physical examinations. This evidence concerns the gene C9orf50 and colorectal carcinoma.